H. Donlon Skerrett
Management & Marketing Consulting
NANOSCAN IMAGING, LLC (NSI) was founded in August 2005 to manage the clinical development of N1177, a water insoluble, iodinated nanoparticle contrast agent used to improve the clinical utility of computed tomography (CT). NSI believes that N1177 will enhance diagnostic imaging’s utility in diagnosing and managing cardiovascular disease and cancer less invasively and less costly than current contrast agents. |

|
N1177 has unique properties that make it a versatile agent with a range of applications including:
1) N1177-iv (Intravenous delivery for enhancing cardiovascular images highlighting areas containing vulnerable plaque)
2) N1177-inh (Inhalation delivery for enhancing image acquisition for lung cancer staging)
3) N1177-sq (Subcutaneous delivery for image acquisition in staging metastatic cancers)
We’re giving CT a whole new way of looking at cardiovascular disease and cancer. |
 |
Management & Marketing Consulting -- Don Skerrett is Managing Partner of Corporate Development Advisors, a senior-level healthcare consulting practice that includes 19 practitioners and has offices in Philadelphia, Boston and the San Francisco Bay area. Mr. Skerrett’s areas of expertise include strategic healthcare marketing, business intelligence, reimbursement, the nursing crisis, the DME market, medical devices, hospital asset management, and the development of strategic business alliances. He has founded and run several companies in addition to Corporate Development Advisors.
Mr. Skerrett began his career at SmithKline, where he helped establish Dyazide as a leader in the diuretic/antihypertensive market.
He helped launch Sine-Off and Love Cosmetics. He has worked with a number of Johnson & Johnson companies and played a significant role in the launch of J&J’s Diversion Magazine which was later sold to Hearst. As VP, Creative Director and Account Management Supervisor at Kingswood Advertising, Skerrett directed work on the Wyeth-Ayerst, Fox Chase and American Academy of Pediatrics accounts, for which he won several awards.
He is co-founder of the Interactive Advertising Council in Washington, DC. He has judged national advertising competitions: the MPA’s Kelly Awards and Editor & Publisher’s “Best in Print.” Mr. Skerrett is a Penn graduate and received a Masters from the Annenberg School for Communication.
|
 |
Contact Info:

Companies:
CEO, NanoScan Imaging, LLC
2250 Berks Road
Lansdale, PA 19446

Tel: (215) 699-1703
Web: www.nanoscanimaging.com
Managing Partner:
Corporate Development Advisors
89 Bunker Hill Court
Wayne, PA 19087

Tel: (610) 647-3231
Cell: (610) 608-1569
Other:
PCCI (Pharmaceutical Consulting Consortium, Inc.)
President

Email: don@rxpcci.com
Web: www.rxpcci.com
|